CFL1 and cancer: Although future studies are needed to determine the role of ACTB and ACTG1 mutations as driver or passenger mutations in different cancers, our data show a possible link between impaired cytoskeletal actomyosin dynamics, cofilin-mediated actin turnover, and cancer development.